KPL-387

N/A

Report date: 2026/05/21 20:00:22

Base Information

Drug NameKPL-387
Drug Alias NameKPL-387
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionInterleukin-1 receptor bindersInterleukin-1 beta inhibitorsInterleukin-1 alpha inhibitors
TargetsInterleukin-1 receptorInterleukin-1 betaInterleukin-1 alpha
Therapy Area/IndicationsPericarditisHeart Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPoland +[10] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesKiniksa Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKiniksa Pharmaceuticals International PLCKiniksa Pharmaceuticals GmbH
Inactive CompaniesN/A
Active IndicationsPericarditisHeart Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A